Status:
COMPLETED
Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity
Lead Sponsor:
Royal College of Surgeons, Ireland
Collaborating Sponsors:
The Rotunda Hospital
Conditions:
Postmenopausal Bleeding
Endometrial Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Postmenopausal bleeding (PMB) is the occurrence of vaginal bleeding 12 months following a woman's last menstrual cycle. PMB represents one of the most common reasons for referral to gynaecology servic...
Eligibility Criteria
Inclusion
- Postmenopausal
- Postmenopausal bleeding
- Tolerates hysteroscopy
Exclusion
- Premenopausal
- Any lesion requiring biopsy at time of hysteroscopy
- Obvious cause of bleeding from the vagina or cervix at time of hysteroscopy
- History of endometrial hyperplasia/cancer
Key Trial Info
Start Date :
September 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05378152
Start Date
September 24 2022
End Date
February 25 2024
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rotunda hospital
Dublin, Ireland